199 related articles for article (PubMed ID: 34342842)
1. Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D.
Li D; Ye JL; Liu ZY
Virol Sin; 2021 Dec; 36(6):1456-1464. PubMed ID: 34342842
[TBL] [Abstract][Full Text] [Related]
2. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
[TBL] [Abstract][Full Text] [Related]
3. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
4. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
[TBL] [Abstract][Full Text] [Related]
5. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
[TBL] [Abstract][Full Text] [Related]
6. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
[TBL] [Abstract][Full Text] [Related]
7. Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus.
Dong HL; Wang HJ; Liu ZY; Ye Q; Qin XL; Li D; Deng YQ; Jiang T; Li XF; Qin CF
Emerg Microbes Infect; 2021 Dec; 10(1):1739-1750. PubMed ID: 34379047
[TBL] [Abstract][Full Text] [Related]
8. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
Jia Q; Jia C; Liu Y; Yang Y; Qi J; Tong L; Chen H; Zhang M; Che J; Li B; Li Z
Antiviral Res; 2019 Feb; 162():1-4. PubMed ID: 30529359
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
[TBL] [Abstract][Full Text] [Related]
11. Generation of a reporter yellow fever virus for high throughput antiviral assays.
Sanchez-Velazquez R; de Lorenzo G; Tandavanitj R; Setthapramote C; Bredenbeek PJ; Bozzacco L; MacDonald MR; Clark JJ; Rice CM; Patel AH; Kohl A; Varjak M
Antiviral Res; 2020 Nov; 183():104939. PubMed ID: 32980446
[TBL] [Abstract][Full Text] [Related]
12. Specialized
Li D; Lu HT; Ding YZ; Wang HJ; Ye JL; Qin CF; Liu ZY
J Virol; 2023 Apr; 97(4):e0194922. PubMed ID: 37017533
[TBL] [Abstract][Full Text] [Related]
13. Limited evolution of the yellow fever virus 17d in a mouse infection model.
Kum DB; Mishra N; Vrancken B; Thibaut HJ; Wilder-Smith A; Lemey P; Neyts J; Dallmeier K
Emerg Microbes Infect; 2019; 8(1):1734-1746. PubMed ID: 31797751
[TBL] [Abstract][Full Text] [Related]
14. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
[TBL] [Abstract][Full Text] [Related]
16. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
[TBL] [Abstract][Full Text] [Related]
17. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
[TBL] [Abstract][Full Text] [Related]
18. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
19. Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti.
Danet L; Beauclair G; Berthet M; Moratorio G; Gracias S; Tangy F; Choumet V; Jouvenet N
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007299. PubMed ID: 31412040
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes.
McElroy KL; Tsetsarkin KA; Vanlandingham DL; Higgs S
J Gen Virol; 2005 Jun; 86(Pt 6):1747-1751. PubMed ID: 15914853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
